Elsevier

Genomics

Volume 43, Issue 1, 1 July 1997, Pages 1-8
Genomics

Regular Article
Suggestive Evidence for a Schizophrenia Susceptibility Locus on Chromosome 6q and a Confirmation in an Independent Series of Pedigrees

https://doi.org/10.1006/geno.1997.4815Get rights and content

Abstract

We have investigated whether there is a locus on chromosome 6 that confers an increased susceptibility to schizophrenia using a two-stage approach and nonparametric linkage analysis. Allele sharing identical by descent (IBD) and multipoint maximum likelihood score (MLS) statistics were employed. Results from two tested data sets, a first data set, or genome scanning data set, and a second replication data set, show excess allele sharing for multiple markers in 6q, a chromosomal region not previously reported as linked to schizophrenia. In our genome scanning data set, excess allele sharing was found for markers on 6q13–q26. The greatest allele sharing was at interval 6q21–q22.3 at marker D6S416 (IBD percentage 69;P= 0.00024). The multipoint MLS values were greater than 2.4 in the 11.4-cM interval delimited by D6S301 and D6S303, with a maximum value of 3.06 close to D6S278 and of 3.05 at D6S454/D6S423. We did not confirm, however, the previously described linkage in 6p, when tested in the systematic genome scanning data set. The replication data set also showed excess allele sharing in chromosomal area 6q13–q26, which overlapped with the aforementioned positive linkage area of the genome scanning data set. The highest sharing of the second data set was at D6S424 (IBD percentage 64;P= 0.0004), D6S283 (IBD percentage 62;P= 0.0009), and D6S423 (IBD percentage 63;P= 0.0009). Multipoint MLS analysis yielded MLS values greater than 1 in an area of about 35 cM, which overlaps with the MLS multipoint area of linkage from the genome scanning data set. The multipoint MLS at the D6S454/D6S423 locus was 2.05. In the second data set, the maximum multipoint MLS was located about 10 cM centromeric from the maximum of the genome scanning data set, at the interval D6S424–D6S275 (2.35). Our results provide very suggestive evidence for a susceptibility locus for schizophrenia in chromosome 6q from two independent data sets.

References (44)

  • T. Holland et al.

    A balanced chromosomal translocation partially co-segregating with psychotic illness in a family

    Psychiatry Res.

    (1990)
  • M.T. Tsuang et al.

    The genetics of schizophrenia: Current knowledge and future directions

    Schizophr. Res.

    (1991)
  • Diagnostic and Statistical Manual of Mental Disorders

    (1987)
  • R. Axelsson et al.

    Chromosome aberrations in patients with paranoid psychosis

    Hereditas

    (1984)
  • A. Bertelsen

    Controversies and consistencies in psychiatric genetics

    Acta Psychiatr. Scand. Suppl.

    (1985)
  • R.W. Cottingham et al.

    Faster sequential genetic linkage computations

    Am. J. Hum. Genet.

    (1993)
  • M.J. Daly et al.

    The importance of being independent: Sib pair analysis in diabetes

    Nature Genet.

    (1996)
  • J.L. Davies et al.

    A genome-wide search for human type 1 diabetes susceptibility genes

    Nature

    (1994)
  • L.E. DeLisi et al.

    Clinical features of illness in siblings with schizophrenia or schizoaffective disorder

    Arch. Gen. Psychiatry

    (1987)
  • C. Dib et al.

    A comprehensive genetic map of the human genome based on 5,264 microsatellites

    Nature

    (1996)
  • J. Endicott et al.

    A diagnostic interview: The schedule for affective disorders and schizophrenia

    Arch. Gen. Psychiatry

    (1978)
  • P.V. Gejman et al.

    Linkage analysis of fifty-seven microsatellite loci to bipolar disorder

    Neuropsychopharmacology

    (1993)
  • E.S. Gershon et al.

    A controlled family study of chronic psychoses: Schizophrenia and schizoaffective disorder

    Arch. Gen. Psychiatry

    (1988)
  • S. Ghosh et al.

    Methods for precise sizing, automated binning of alleles, and reduction of error rates in large-scale genotyping using fluorescently labeled dinucleotide markers

    Genome Res.

    (1997)
  • Gottesman et al.

    Confirming unexpressed genotypes for schizophrenia: Risks in the offspring of Fischer's Danish identical and fraternal discordant twins

    Arch. Gen. Psychiatry

    (1989)
  • H. Gurling et al.

    Schizophrenia susceptibility and chromosome 6p24–22

    Nature Genet

    (1995)
  • S.E. Hodge

    The information contained in multiple sibling pairs

    Genet. Epidemiol.

    (1984)
  • P. Holmans

    Asymptotic properties of affected-sib-pair linkage analysis

    Am. J. Hum. Genet.

    (1993)
  • P. Holmans et al.

    Efficiency of typing unaffected relatives in an affected-sib-pair linkage study with single-locus and multiple tightly linked markers

    Am. J. Hum. Genet.

    (1995)
  • K.S. Kendler

    Familial aggregation of schizophrenia and schizophrenia spectrum disorders. Evaluation of conflicting results

    Arch. Gen. Psychiatry

    (1988)
  • K.S. Kendler et al.

    The Roscommon Family Study. I. Methods, diagnosis of probands, and risk of schizophrenia in relatives

    Arch. Gen. Psychiatry

    (1993)
  • Cited by (204)

    • Pharmacology of human trace amine-associated receptors: Therapeutic opportunities and challenges

      2017, Pharmacology and Therapeutics
      Citation Excerpt :

      In mammals, TAAR genes are arranged as a single cluster on an individual chromosome, with the human cluster mapping to chromosome 6q23.2 (Borowsky et al., 2001; Bunzow et al., 2001). This position may have therapeutic relevance as it coincides with a putative susceptibility locus for schizophrenia (Cao et al., 1997; Kaufmann et al., 1998; Levinson et al., 2000) and affective disorders (Venken et al., 2005). Whilst TAARs were not among the 108 genes recently identified by a large genome-wide association study focusing on schizophrenia (Schizophrenia Working Group of the Psychiatric Genomics Consortium, 2014), a recent study has reported an association of rare TAAR1 variants with schizophrenia (John et al., 2017).

    • A preliminary study of endocannabinoid system regulation in psychosis: Distinct alterations of CNR1 promoter DNA methylation in patients with schizophrenia

      2017, Schizophrenia Research
      Citation Excerpt :

      The dysregulation of the ECS has been already reported in schizophrenic patients (Giuffrida et al., 2004; Bossong et al., 2014; Saito et al., 2013; Kucerova et al., 2014; Volk and Lewis, 2015) and our present findings corroborate and extend previous studies suggesting a specific association of CNR1 with SZ (Leroy et al., 2001; Ashton and Moore, 2011; Volk et al., 2014). Of note, data shown here are supported also by localization of CNR1 on chromosome 6q14–15, widely considered a susceptibility locus for SZ (Cao et al., 1997). Post-mortem studies reported CB1 abnormalities in cortical areas through binding studies that showed increased receptor activity in patients with SZ (Dean et al., 2001; Zavitsanou et al., 2004; Newell et al., 2006; Dalton et al., 2011).

    • The Endocannabinoid System and Human Brain Functions: Insight From Memory, Motor, and Mood Pathologies

      2017, The Endocannabinoid System: Genetics, Biochemistry, Brain Disorders, and Therapy
    • Trace Amines and Their Receptors in the Control of Cellular Homeostasis

      2016, Trace Amines and Neurological Disorders: Potential Mechanisms and Risk Factors
    View all citing articles on Scopus
    1

    To whom correspondence should be addressed at Unit on Molecular Clinical Investigation, Clinical Neurogenetics Branch, 10-4N320, NIMH, 10 Center Drive, MSC 1274, Bethesda, MD 20892-1274. Telephone: (301) 402-2396. Fax: (301) 480-2152. E-mail: [email protected].

    View full text